Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $4.03B | $4B | +0.90% |
Cost of Revenue | $1.32B | $1.2B | +10.34% |
Gross Profit | $2.71B | $2.8B | -3.15% |
Operating Income | $545.75M | $607.63M | -10.18% |
Net Income | $410.35M | $421.36M | -2.61% |
EPS (Basic) | $5.66 | $5.63 | +0.53% |
EPS (Diluted) | $5.65 | $5.62 | +0.53% |
R&D Expense | $369.91M | $364.2M | +1.57% |
SG&A Expense | $1.76B | $1.76B | -0.42% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $6.23B | $6.21B | +0.31% |
Current Assets | $2.62B | $2.49B | +4.98% |
Total Liabilities | $2.18B | $2.36B | -7.54% |
Current Liabilities | $1.92B | $2.04B | -5.79% |
Stockholders' Equity | $4.05B | $3.85B | +5.12% |
Cash & Equivalents | $1.09B | $1.04B | +4.89% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $593.22M | $738.23M | -19.64% |
Investing Cash Flow | $-112.44M | $-254.91M | +55.89% |
Financing Cash Flow | $-464.58M | $-355.72M | -30.60% |
Share Buybacks | $465.94M | $352.88M | +32.04% |
D&A | $237.44M | $145.03M | +63.71% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 67.2% | 70.0% | -2.81% |
Operating Margin | 13.5% | 15.2% | -1.67% |
Net Margin | 10.2% | — | — |
ROE | 10.1% | — | — |
ROA | 6.6% | — | — |
Current Ratio | $1.363 | — | — |
Debt to Equity | $0.54 | — | — |
ALGN experienced modest revenue growth, but rising costs led to decreased profitability and cash flow challenges in 2025.
The company achieved a slight revenue increase of 0.9% year-over-year, driven by steady demand for its orthodontic products.
Source: Source: 10-K Income Statement, p.1
Cost of revenue increased by 10.3%, significantly impacting gross profit, which declined by 3.1%.
Source: Source: 10-K Income Statement, p.1
Operating cash flow decreased by 19.6%, reflecting higher operational costs and impacting liquidity.
Source: Source: 10-K Cash Flow Statement, p.1
The company faces increasing costs of revenue, which grew by 10.3% year-over-year, potentially squeezing margins further if not managed.
Source: Source: 10-K Income Statement, p.1
Unlock 2 more detailed risk analysis
Upgrade to unlockOther companies in Health Care